1982
DOI: 10.1001/archderm.1982.01650150035018
|View full text |Cite
|
Sign up to set email alerts
|

Diffuse Cutaneous Reticulohistiocytosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
16
0
1

Year Published

1985
1985
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(18 citation statements)
references
References 20 publications
1
16
0
1
Order By: Relevance
“…8 Several patterns emerge in the temporal relationship between MRH and malignancy as reported in the English-language literature (Table I). In most cases, the onset of malignancy and MRH occurred within about 2 years of each other, [9][10][11][12][13][14][15][16] or the presentation of MRH prompted a workup and subsequent detection of malignancy. [17][18][19][20][21][22] However, the onset of MRH may also occur closer to the time of recurrence or metastasis of a previously diagnosed and treated malignancy.…”
Section: Discussionmentioning
confidence: 99%
“…8 Several patterns emerge in the temporal relationship between MRH and malignancy as reported in the English-language literature (Table I). In most cases, the onset of malignancy and MRH occurred within about 2 years of each other, [9][10][11][12][13][14][15][16] or the presentation of MRH prompted a workup and subsequent detection of malignancy. [17][18][19][20][21][22] However, the onset of MRH may also occur closer to the time of recurrence or metastasis of a previously diagnosed and treated malignancy.…”
Section: Discussionmentioning
confidence: 99%
“…Reticulohistiocytosis is a rare, non‐Langerhans histiocytic disorder of unknown aetiology. It comprises a disease spectrum that ranges from purely cutaneous ‘benign’ forms; namely, solitary cutaneous reticulohistiocytoma and multiple cutaneous reticulohistiocytosis (MCR), to the more aggressive form of multicentric reticulohistiocytosis (MR) with systemic involvement (arthropathy or visceral) and concomitant cutaneous lesions . Malignancy has been regarded as an underlying cause in about a quarter of patients with MR, but has not been reported in MCR .…”
Section: Introductionmentioning
confidence: 99%
“…MR was initially described in 1954. It is now considered a form of histiocytosis that is characterized by papulonodular cutaneous lesions and destructive, deforming, symmetrical arthritis 1–3 . Lesions of the skin have a predilection for the hands with a characteristic periungual ‘coral‐bead’ appearance.…”
Section: Discussionmentioning
confidence: 99%